The Class Morning Show is a weekly programme aired from 5:50 am to 10:00 am (Monday – Friday) that targets the mature working professional aged between 18-60 years and has a strong interest in social, ...
Research led by the University of Michigan's Kresge Hearing Research Institute and the University of Rochester illuminates the mechanisms through which humans can pick out and focus on single sounds ...
The ‘F*** Around, Find Out’ approach puts consequences front and centre — but are children’s developing brains ready for it? Move over ‘helicopter’ and ‘tiger’ parenting, the latest approach which ...
From the 2026-27 academic year, India will introduce AI education for students from Class 3 onwards, aligning with NEP 2020. CBSE is developing frameworks and training over one crore teachers. Pilot ...
Please Note: All times UK. Tables are subject to change. The BBC is not responsible for any changes that may be made. Manager: Matjaz Kek Formation: 5 - 4 - 1 Manager: Murat Yakin Formation: 4 - 3 - 3 ...
Growing up in the public eye is tough for any kid but when your father is an U.S. president, privacy becomes almost impossible. Throughout Donald Trump’s time in the White House, First Lady Melania ...
Please Note: All times UK. Tables are subject to change. The BBC is not responsible for any changes that may be made. Manager: Dragan Stojkovic Formation: 3 - 4 - 1 - 2 Manager: Sylvinho Formation: 4 ...
That's an absolute worldie. You see it so often these days, wingers on the opposite side. I think David Brooks doesn't think Saka can do what he does, that is world class. Out. Of. This. World. That's ...
Colchester won their first three home league matches against Harrogate Town but they’ve lost their last two. All five games between the sides in Essex have been won by one goal. After losing five of ...
Austria national team captain David Alaba has praised his compatriot Konrad Laimer for his impressive start to the season with Bayern Munich. The Real Madrid defender, who shares a long-standing ...
These long-term findings in a large patient cohort show the sustained clinical efficacy and safety of autologous CD34+ hematopoietic stem-cell lentiviral gene therapy for ADA-SCID, indicating that it ...